Results

Total Results: 2,639 records

Showing results for "absence".

2061. Overview of Prostate Cancer Screening Decision Models: A Contextual Review for the U.S. Preventive Services Task Force (pdf file)
      www.uspreventiveservicestaskforce.org/Home/GetFile/1/16813/prostate-cancer-models-overview/pdf
      May 01, 2018 - the Prostate Cancer Screening Decision Models 6 Kaiser Permanente EPC/University of Arizona absence … screen- detected cancer that would not have been clinically detected during a patient’s lifetime in the absence

2062. Overview of Prostate Cancer Screening Decision Models: A Contextual Review for the U.S. Preventive Services Task Force (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/vTHBrY6VuqjoouJvUmtkr4
      May 01, 2018 - the Prostate Cancer Screening Decision Models 6 Kaiser Permanente EPC/University of Arizona absence … screen- detected cancer that would not have been clinically detected during a patient’s lifetime in the absence

2063. Pediatric Patient Safety Consortium (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA205-Materials_XIII.pdf
      August 13, 2014 - A) Is the item useful in the absence of an illness or injury? B) Explain: 11a.) … nature: Item is primarily and customarily used to serve a medical purpose and is not useful in the absence

2064. Pediatric Patient Safety Consortium (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA204-Materials_XIII.pdf
      August 25, 2014 - A) Is the item useful in the absence of an illness or injury? B) Explain: 11a.) … nature: Item is primarily and customarily used to serve a medical purpose and is not useful in the absence

2065. Pediatric Patient Safety Consortium (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA202-Materials_XIII.pdf
      January 01, 2014 - A) Is the item useful in the absence of an illness or injury? B) Explain: 11a.) … nature: Item is primarily and customarily used to serve a medical purpose and is not useful in the absence

2066. Disposition of Comments Report for Treatment of Atrial Fibrillation (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation_disposition-comments.pdf
      June 28, 2013 - lines 51-52 - I have not seen this recommendation before, regarding rhythm control strategies in the absence … younger patients (<65 years of age), a rhythm-control strategy is often considered reasonable in the absence

2067. Disposition of Comments Report for Nitrous Oxide for the Management of Labor Pain (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/labor-nitrous-oxide_disposition-comments.pdf
      August 23, 2012 - therefore, pain relief is likely to be an inadequate measure of effectiveness for nitrous oxide in the absence … clear, but probably relate to the ease of nitrous oxide administration, its lack of flammability, absence

2068. GRADING THE STRENGTH OF A BODY OF EVIDENCE (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-grading-evidence_methods.pdf
      November 01, 2013 - Score as one of two levels: • Strong: Large effect size that is unlikely to have occurred in the absence … This case includes the absence of any relevant studies whatsoever.

2069. Vte-Prophyalaxis Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/vte-prophyalaxis_executive.pdf
      May 01, 2013 - risk of bias rating due to methodologic limitations in design and reporting, sample size, and the absence … In the absence of high-quality studies, we were unable to determine the comparative effectiveness and

2070. Microsoft Word - 2011_04.docx (pdf file)
      hcup-us.ahrq.gov/reports/methods/2011_04.pdf
      January 01, 2011 - RBU 015x: Room & Board -Ward RBU 016x: Room & Board -Other RBU 017x: Nursery NUR 018x: Leave of Absence … 173 NUR CHG73 Nursery - Newborn Level IV 174 NUR CHG74 Nursery - Other 179 NUR CHG8 Leave of Absence

2071. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/MzHhsgTBL37rRvvJfkfgMZ
      August 20, 2019 - between coping strategies and anxiety in women from families with familial breast-ovarian cancer in the absence … Psychological distress in women at risk of hereditary breast/ovarian or HNPCC cancers in the absence

2072. Table 2: NIS and NHDS Comparisons by Region, 1999 (pdf file)
      hcup-us.ahrq.gov/reports/methods/1999NISComparisonReportFinal.pdf
      March 08, 2002 - NIS discharge estimates consistently exceed MedPAR estimates, as expected, consistent with the absence … higher for each procedure, and length of stay was generally found to be higher, again, reflecting the absence

2073. Archived: Evidence Summary: Breast and Ovarian Cancer: BRCA Genetic Testing, September 2005 | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-and-ovarian-cancer-brca-testing-screening-2005
      September 15, 2005 - In the absence of direct measures, it can be assumed that half of the mutations would be in BRCA1 and … 180 although several studies are inconclusive. 183-186 Genetic Risk Assessment Strategies In the absence

2074. Evidence-based Practice Center Systematic Review Protocol: Depression in Children: Systematic Review (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/depression-childhood-protocol.pdf
      August 06, 2018 - The absence of information on harms associated with nonpharmacological interventions precludes making … Language Studies published in English Studies published in languages other than English * In the absence

2075. HIT Support for Safe Nursing Care (pdf file)
      digital.ahrq.gov/sites/default/files/docs/publication/r01hs015054-keenan-final-report-2008.pdf
      January 01, 2008 - In the absence of a collective mind, it is nearly impossible to ensure the continuity, safety, and quality

2076. Layout 1 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-2007_executive.pdf
      January 01, 2007 - In the absence of compelling evidence from long-term trials that include assessment of cardiovascular

2077. Mental-Illness-Adults-Prisons Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-illness-adults-prisons_executive.pdf
      August 01, 2013 - studies and both conducted meta-analyses based on a single treatment component (e.g., presence or absence

2078. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/lung-cancer-nonsurgical-therapies_research-protocol.pdf
      February 22, 2012 - include noncomparative observational studies (case series) to assess comparative effectiveness in the absence

2079. Nephropathy-Contrast-Induced Research-Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/nephropathy-contrast-induced_research-protocol.pdf
      October 01, 2013 - or 0.5 mg/dL, occurring within 3 days after intravascular administration of contrast media in the absence

2080. Electronic Health Record Usability - Vendor Practices and Perspectives (pdf file)
      digital.ahrq.gov/sites/default/files/docs/citation/EHRVendorPracticesPerspectives.pdf
      May 01, 2010 - Lack of time, personnel, and budget resources were cited as reasons for this absence; however, the